Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

High-dose Erythropoietin No Benefit for Extreme Preemies

drugsJanuary 20, 2020

Tag: erythropoietin , Treatment , Infant

PharmaSources Customer Service